Structural decomposition and heterogeneity of commercial lipoteichoic Acid preparations
about
Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involvedRecognition of Staphylococcus aureus by the innate immune system.Structural diversity and biological significance of lipoteichoic acid in Gram-positive bacteria: focusing on beneficial probiotic lactic acid bacteriaSynthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine releaseBacillus anthracis peptidoglycan stimulates an inflammatory response in monocytes through the p38 mitogen-activated protein kinase pathway.Relationship between expression of the family of M proteins and lipoteichoic acid to hydrophobicity and biofilm formation in Streptococcus pyogenesEnhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids.Systemic endotoxin levels in chronic indolent periodontal infections.Lipoteichoic acid and lipopolysaccharide can activate antimicrobial peptide expression in the tobacco hornworm Manduca sexta.Conformation of the phosphate D-alanine zwitterion in bacterial teichoic acid from nuclear magnetic resonance spectroscopy.Interaction of neonatal phagocytes with group B streptococcus: recognition and response.A subclass of acylated anti-inflammatory mediators usurp Toll-like receptor 2 to inhibit neutrophil recruitment through peroxisome proliferator-activated receptor gammaDifferential effects of Gram-positive versus Gram-negative bacteria on NOSII and TNFalpha in macrophages: role of TLRs in synergy between the twoA continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteriaSystematic review of membrane components of gram-positive bacteria responsible as pyrogens for inducing human monocyte/macrophage cytokine release.Teichoic acids: synthesis and applications.Use of synthetic derivatives to determine the minimal active structure of cytokine-inducing lipoteichoic acid.Lipoteichoic acid is an important microbe-associated molecular pattern of Lactobacillus rhamnosus GG.Pro-angiogenic activity of TLRs and NLRs: a novel link between gut microbiota and intestinal angiogenesisReview: variability of host-pathogen interaction.Identification of a Lipoteichoic Acid Glycosyltransferase Enzyme Reveals that GW-Domain-Containing Proteins Can Be Retained in the Cell Wall of Listeria monocytogenes in the Absence of Lipoteichoic Acid or Its ModificationsLipoprotein lipase and hydrofluoric acid deactivate both bacterial lipoproteins and lipoteichoic acids, but platelet-activating factor-acetylhydrolase degrades only lipoteichoic acidsLipoteichoic acids, phosphate-containing polymers in the envelope of gram-positive bacteria.Induction of long-term lipopolysaccharide tolerance by an agonistic monoclonal antibody to the toll-like receptor 4/MD-2 complex.Lipoteichoic acids as a major virulence factor causing inflammatory responses via Toll-like receptor 2.Characterization of lipoteichoic acid structures from three probiotic Bacillus strains: involvement of D-alanine in their biological activity.Lipoteichoic acid of Enterococcus faecalis induces the expression of chemokines via TLR2 and PAFR signaling pathways.Peptidoglycan from Staphylococcus aureus induces tissue factor expression and procoagulant activity in human monocytesAutomated solid phase synthesis of teichoic acids.Distribution and kinetics of lipoprotein-bound lipoteichoic acidPneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2.Lipoteichoic acid is important in innate immune responses to gram-positive bacteria.Heterozygous toll-like receptor 2 polymorphism does not affect lipoteichoic acid-induced chemokine and inflammatory responses.Highly purified lipoteichoic acid from Staphylococcus aureus induces procoagulant activity and tissue factor expression in human monocytes but is a weak inducer in whole blood: comparison with peptidoglycan.Enterococcus faecalis lipoteichoic acid suppresses Aggregatibacter actinomycetemcomitans lipopolysaccharide-induced IL-8 expression in human periodontal ligament cells.Theiler's virus infection induces TLR3-dependent upregulation of TLR2 critical for proinflammatory cytokine production.A functional dlt operon, encoding proteins required for incorporation of d-alanine in teichoic acids in gram-positive bacteria, confers resistance to cationic antimicrobial peptides in Streptococcus pneumoniae.Comparison of lipoteichoic acid from different serotypes of Streptococcus pneumoniae.Apolipoprotein B100 is a suppressor of Staphylococcus aureus-induced innate immune responses in humans and mice.Effects of bacterial cell wall components (PAMPs) on the expression of monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha) and the chemokine receptor CCR2 by purified human blood monocytes.
P2860
Q24295020-770E74A7-6257-4FDE-96DD-977BE7E79BFCQ24530569-ABADA412-64BC-4FBD-BE22-E6132C7396E1Q28073013-59006F11-4278-4699-8E90-7452CD36415AQ32135362-5EE47A45-DC97-4142-BB35-72A9C4A6F65DQ33383858-BEAE4FD0-644D-47F4-90B5-C658C44360E8Q33398535-30053F46-7EE1-4C21-A34B-596BA194BCE5Q33900587-FC9E2740-8D3E-4FF2-A1CA-34E007399008Q33917860-39CDFE48-978C-4368-AEA4-CE399326B601Q34037174-95412090-23F8-4136-A6EB-D76FD8CAB513Q34338343-E4953F09-CE63-497A-AC0A-A597747BD22BQ34681095-A2DC64F4-A0DC-4866-B388-AE80113E423BQ35239802-BA1D2196-A35A-4969-ACF5-D54DD3A98C1BQ35546440-D8EFE4A8-B2FD-4E16-BDFC-6B4781336DA4Q35604105-F2F8B5E5-E8C9-4910-A5FE-0EE24D99E4A2Q35893715-E02B0206-1C3A-4463-946C-C4C81D125ED1Q36227693-79173579-ACFB-4358-BEE7-D1957203AD73Q36314103-EE5AB90B-BFD1-4661-A4D7-D80B3C1B6E31Q36510380-F8979ECB-89C1-4B42-9EF8-828889309494Q36625842-A8308325-1847-45B2-8858-656FA798E642Q36980187-4A3E6D9D-9C4F-4873-98A7-041DF4E275FBQ37093366-21F03636-28E5-491A-AC3F-041B89C34001Q37301869-C49B9BC6-88BC-48D5-AAAB-845E4937F66AQ37643417-1D5F5E06-A5B7-4B98-B46C-4BA14DDE0F60Q38499178-663A42B7-DCF4-42BC-92F0-6E8438BFF83BQ38920945-60A6B210-10EB-4A1A-8BA7-06ED1978BE1FQ38968881-FFDD9698-E980-4ACA-9FE0-3E953038FD51Q39107262-A761F04D-54B0-4293-A78C-6E22D050CB8BQ39655309-9B1E11BA-AE0A-4E34-B731-64F394A3DC22Q39731499-252BE358-7217-40AA-B5AA-46F9381259CEQ39755209-355AAD5E-4077-4054-BF37-AA9FDA6C5FFDQ39913078-3C6C8ACE-B47E-473E-A275-5BFC6528B9F9Q40063735-BE0C37AC-136D-488D-9FA1-1F3147881B69Q40634487-5202332A-7F3F-4960-AD93-6E7CBB37A95AQ40936155-766C2B4C-BB03-42BD-BFDD-9E7930362B9EQ41357708-9AC99C77-49B9-4020-B82F-F3C2D5FE6677Q42198267-7E65DA1C-2AF1-4912-BB92-44FB0975B3B6Q42578089-B59F9EAC-B337-4F82-8AE5-0DA2D3C09153Q42596969-88F0DEA1-837E-4E45-8C67-C3E68AF7AFB2Q44192854-8683018C-1BE0-4C1E-8B2B-DCA00E1C9374Q44560047-ADB54786-C90E-41D5-B96E-16D6AB9CAF77
P2860
Structural decomposition and heterogeneity of commercial lipoteichoic Acid preparations
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Structural decomposition and heterogeneity of commercial lipoteichoic Acid preparations
@en
Structural decomposition and heterogeneity of commercial lipoteichoic Acid preparations.
@nl
type
label
Structural decomposition and heterogeneity of commercial lipoteichoic Acid preparations
@en
Structural decomposition and heterogeneity of commercial lipoteichoic Acid preparations.
@nl
prefLabel
Structural decomposition and heterogeneity of commercial lipoteichoic Acid preparations
@en
Structural decomposition and heterogeneity of commercial lipoteichoic Acid preparations.
@nl
P2093
P2860
P1476
Structural decomposition and heterogeneity of commercial lipoteichoic Acid preparations
@en
P2093
Armin Geyer
Corinna Hermann
Ingo Spreitzer
Siegfried Morath
Thomas Hartung
P2860
P304
P356
10.1128/IAI.70.2.938-944.2002
P407
P577
2002-02-01T00:00:00Z